UK caves to pharma demands in Swiss trade deal — despite NHS cost fears

An extra 229,000 deaths: Is that the cost of US-UK drugs deal?

Research finds that trade deal requiring UK to buy more medicines from US takes away money from other parts of NHS.

A US-UK Pharmaceutical Deal Could Cause 229,000 Extra Deaths in Britain, BMJ Study Warns

A study in the British Medical Journal finds that Britain's pharmaceutical deal with the US will divert £44.7 billion from NHS care by 2036, causing 229,000 excess deaths. The government says the deal expands patient access to life-changing medicines; BMJ researchers say it robs finite NHS resources from cardiovascular, cancer, and respiratory treatments.

NHS Drug Deal Could Cause 200,000 Avoidable Deaths

The NHS will be forced to divert billions of pounds from essential services to pay more for new drugs under the terms of the UK-US trade deal, according to new analysis, after ministers caved to pressure from president Donald Trump over tariffs. The trade deal is also projected to lead to over 200,000 excess deaths []

Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities

Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities

Broker’s Call: Mankind Pharma (Add)

InCred Equities

Don't Buy UnitedHealth Group (UNH) Stock Before Reading This

The healthcare industry is growing, but UnitedHealth Group may not be the best healthcare investment around.

Forget French: The American Pharmacy Products Tourists Are Hoarding For Home

U.S. tourists love French pharmacies. But what should FIFA-bound visitors pick up stateside? Here’s the most popular American pharmacy buys they could hoard.

‘Big changes’: Crick to stop paying for hybrid open access

Leading biomedical research institute says it will “go full in on green and gold” The post ‘Big changes’: Crick to stop paying for hybrid open access appeared first on Research Professional News.

Your pharmacist is there to help: Why South Africans can trust their local pharmacy professional

For many South Africans, a pharmacy visit is quick: pop in, get what you need, and leave. But it can offer far more than that. Your pharmacist does more than hand over medicine. They can help you choose the right treatment, use it properly, and stay safe. Taking a moment to speak to them gives []

Patients pay the price as ever, as costs continue to mount - The Irish News view

Irish News editorial on why patients pay the price as ever as costs continue to mount

Buying prescription-only drugs over the counter abroad is the ultimate holiday souvenir. Here's what happens to your body if you take weight-loss jabs from Thailand or insomnia pills from the US - and the medication that could be fatal

Buying prescription-only drugs over the counter abroad is the ultimate holiday souvenir. Here's what happens to your body if you take weight-loss jabs from Thailand or insomnia pills from the US - and the medication that could be fatal

Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage

Many Americans are shopping around for affordable options as the cost of health insurance soars. But some who hope to keep the same doctors and medications face a thicket of red tape and disruption after they switch plans.

Hospitals Forcing Exclusive Prescriptions Now On FDA's Radar: Tukaram Mundhe

FDA Commissioner Tukaram Mundhe tells NDTV Profit in an exclusive interview that Maharashtra's drug regulators are cracking down on hospital pharmacies that force patients into exclusive...

The most quietly significant day of the decade is about to arrive

Stefano Hatfield: Weight-loss drugs in pill form will change Britain more than any of us can anticipate

Substack 4: Nutrition Researchers Say It’s the Doctors Who Are Fooling Themselves – Are They?

The very controversial history surrounding dietary therapy for obesity and diabetes comes down to one consistent and very obvious conflict. Physicians, like the UK’s David Unwin in his recent article, insist that they know better how to successfully treat their patients than the academic nutritionists and epidemiologists in their Ivy Towers. The physicians have argued...Read More »

UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union

UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union

Form 4 ANI Pharmaceuticals Inc For: 6 July

Form 4 ANI Pharmaceuticals Inc For: 6 July

The Useless Middlemen Making Prescriptions Unaffordable

Pharmacy benefit managers sit at the center of a four-way transaction between patients, insurers, drug manufacturers, and pharmacies. They’ve figured out how to skim profit from every single one of those relationships, explains Senate candidate Abdul El-Sayed.

130 million kronor for global health

130 million kronor for global health

Antibiotic resistance and E. coli: The hidden crisis fueling inflammatory bowel disease

(NaturalNews) The reckless overuse of broad-spectrum antibiotics, driven by Big Pharma's profit motive and corruption within medical and agricultural systems, h...

Profits over health? Inside story of India's U-turn on carcinogenic fungicide Thiram

Profits over health? Inside story of India's U-turn on carcinogenic fungicide Thiram

PGH, IWTS  launches country’s first charity bone marrow transplant unit

The country’s first charity bone marrow transplant unit was opened at the Philippine General Hospital (PGH) on Friday, aiming to help Filipinos with blood-related diseases gain better access to the typically high-cost procedure. The facility makes PGH the country’s first public hospital to offer bone marrow transplantation, a treatment that was previously available only in []

US launches investigation into drug prices in Germany, risking renewed tensions with Europe

Donald Trump claims that European healthcare systems, which regulate drug prices, are to blame for the high prices charged by pharmaceutical companies in the US.

HLB liver cancer drug hits FDA setback again over manufacturing issues

HLB's hopes of bringing its liver cancer treatment to the US market have suffered another blow after the US Food and Drug Administration issued a Complete Response Letter delaying approval, citing manufacturing compliance issues rather than concerns over the drug's clinical data. HLB said Friday that its US subsidiary, Elevar Therapeutics, received the CRL from the FDA regarding its new drug application for Rivoceranib, an anti-cancer therapy intended for use in the treatment of liver cancer. Ac

Space labs open new frontier for Korean drugmakers

Space labs open new frontier for Korean drugmakers

USTR Announces Investigation of Germany’s Unfair Pharmaceutical Pricing

The U.S. is the global leader in pharmaceutical research and development, and foreign countries have been taking advantage of this investment by not paying their fair share of those costs. On June 18, 2026, the Trump administration took a step in the right direction to resolve this problem when the United States Trade Representative (USTR) []

Why Has US Launched a Trade Investigation Into Germany Over Drug Pricing?

The United States has launched a Section 301 trade investigation into Germany's proposed pharmaceutical spending reforms to determine whether they are unreasonable or discriminatory toward innovative drugmakers. The probe follows Berlin's efforts to address a 20 billion healthcare funding gap and could eventually lead to tariff-related action on German imports if US authorities find unfair trade practices.

Quesnel, B.C., rolling out the red carpet to attract U.S.-trained doctors — and it's working

The community of Quesnel in northern B.C. is pulling out all the stops to attract U.S.-trained physicians and solve previously long waits for family doctors. A health-care recruiter in the community of around 10,000 people says the so-called red carpet approach is working — with at least four doctors committed to work there by the end of the summer.

Every euro invested in innovative medicines yields 5.67 euros, EFPIA finds

An analysis carried out across 29 European countries between 2014 and 2024 quantifies, for the first time, the economic and social value of pharmaceutical innovation: 66 billion euros in total benefits, comprising hospital savings and productivity gains

ACA Marketplace premiums are rising sharply. What caused this?"

Health insurance through the Affordable Care Act marketplaces is more expensive than ever. Forbes Senior Healthcare Contributor Bruce Japsen tells NPR's Elissa Nadworny how we got here.

Health board apologizes for phishing staff with with bogus vacation day

IT thought a fake offer of extra time off for hard-pressed Canadian medical workers was the way to go

Stripe, Anthropic, and OpenAI are backing an effort to stop respiratory infections

The common cold comes for us all—often more than once a year. And there is no way to prevent it. The best you can do is take vitamin C and stay away from people with the sniffles. Now the payment company Stripe, founded by brothers Patrick and John Collison, says it will fund a new

Finland’s CurifyLabs raises $14M to 3D-print personalised medicine in the US

Your prescription, printed to order. A Finnish startup wants to turn the back room of your pharmacy into a tiny, automated drug factory, and it just raised 14m to do it in America. CurifyLabs has closed a 14m (12m) Series A, the company announced. The Helsinki firm makes machines and software that let pharmacies 3D-print [] This story continues at The Next Web

How hospitals are profiting from a program meant for low-income patients

Washington is increasingly tapping a hidden “piggy bank” to fund its growing healthcare commitments. Proponents of this strategy proclaim that it doesn’t cost taxpayers a dime, but that’s an illusion. It’s quietly draining one of America’s most important industries — and threatens to degrade millions of Americans’ health while greatly increasing future healthcare spending. Each []

Recognise community pharmacies as primary healthcare centres – ACPN tells FG

Pharmacists under the auspices of Association of Community Pharmacists of Nigeria, ACPN, have called on the federal government to without waisting more time, recognise community pharmacies as primary healthcare centres. ACPN National Chairman, Pharmacist Ambrose Ezeh made this suggestion in a statement made available to DAILY POST on Tuesday. Ezeh said that the presence of pharmacies [] Recognise community pharmacies as primary healthcare centres – ACPN tells FG